UW Center for Tobacco Research and Intervention
Wisconsin Public Radio interviewed UW-CTRI Director of Clinical Services Dr. Doug Jorenby about youth vaping. To see Dr. Jorenby’s research on people who both smoke and vape, click here.
In a city that displays art by the likes of Michelangelo and Leonardo da Vinci, five UW-CTRI staff members presented research findings to peers at the 2017 Society for Research on Nicotine and Tobacco (SRNT) Annual Meeting March 8-11. UW-CTRI Associate Research Director Dr. Megan Piper (above) served as the discussant at the symposium “Time-varying …
Factorial designs are highly efficient and useful in evaluating clinical intervention components, but only when done correctly, according to a new paper in Behavioral Therapy. The paper, by a slew of UW-CTRI researchers led by corresponding author and UW-CTRI Research Director Dr. Tim Baker, serves as a primer to help researchers determine when a factorial …
UW-CTRI staff will present results from various projects pertaining to tobacco research and outreach at the 2017 National Conference on Tobacco or Health in Austin, Texas March 22-24. Here’s a rundown: For a preview of UW-CTRI presentations at the annual conference of the Society for Research on Nicotine and Tobacco (SRNT), click here.
UW Health is set to implement a system to refer patients who want to quit smoking to the Wisconsin Tobacco Quit Line (WTQL), using their electronic health record (EHR), referred to as eReferral, in all its outpatient clinics by the middle of 2017. UW Health’s Yahara Clinic is piloting the system in its electronic health …
UW-CTRI Associate Director of Research Dr. Megan Piper was voted Secretary/Treasurer of the Society for Research on Nicotine and Tobacco (SRNT) for a second 3-year team, the society announced. Piper will continue to serve as part of the SRNT Board of Directors, participating in monthly conference calls with Executive Director Bruce Wheeler and other board members. In …
(Status: Data under analysis for dissemination) Most smokers who try to quit do not succeed. Even if they use evidence-based treatment, only approximately 10% to 30% achieve long-term abstinence. It is known that strong craving for cigarettes is a powerful reason many smokers fail in their quit attempts. Unfortunately, medication and cessation counseling are only …
The FDA has removed the boxed warning regarding serious neuropsychiatric events from two stop-smoking medicines, varenicline (Chantix) and bupropion (Zyban). Based on a review of a large clinical trial, FDA has determined the risk of serious side effects on mood, behavior, or thinking is lower than previously suspected. The risk of these mental health side effects is still …
A new report from the U.S. Surgeon General raises public health concerns about e-cigarette use among U.S. youth and young adults. The report comes amid alarming rates of youth and young adult use of e-cigarettes; in 2015, about 1 in 6 high school students used an e-cigarette in the past month. The report finds that, while nicotine …